NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

29 hedge funds and large institutions have $991K invested in NeuBase Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$350K
2
$285K
3
$77K
4
$76K
5
$49K
6
$35K
7
$25K
8
$15K
9
$14K
10
$13K
11
$12K
12
$9K
13
$7K
14
$6K
15
$3K
16
$3K
17
$3K
18
$2K
19
$2K
20
$2K
21
$1K
22
$1K
23
$1K
24
25